medigraphic.com
Órgano de Difusión de la Asociación Académica Panamericana de Medicina Familiar A.C.

2020, Number 1

<< Back Next >>

Arch Med Fam 2020; 22 (1)

Prevalence of Sarcopenia by Age Groups in a Population of Mexico City

Godínez-Escobar K, Gallegos-De Luna C, Meneses-Acero I, Vargas-Ayala G, Ovando-Hurtado JP, Guerrero-García C, Rubio-Guerra AF

Language: Spanish
References: 23
Page: 7-12
PDF size: 157.23 Kb.


ABSTRACT

Objective: To determine the prevalence of sarcopenia in our environment, as well as in different age groups. Methods: 293 patients older than 18 years divided into three groups, A1 (18-39 years, 126 subjects), A2 (40-59 years, 96 individuals) and A3 (› 60 years, 71 subjects), were performed the analysis of anthropometric measurements by bioimpedance in an INBODY120. The statistical method was ANOVA. Results: Sarcopenia was found in 45 individuals (15.35%). The group A1 showed sarcopenia in 18 subjects (14.28%) with an Muscle Mass Index (IMM) 9.1 ± 1.06 kg/m2 and muscle mass of 24.7 ± 4.9kg, in group A2 11 individuals (11.45%) present sarcopenia with an IMM of 9.1 ± 0.89 kg/m2 and muscle mass of 22.9 ± 3.5kg, and the group A3 with 16 subjects (22.53%), an IMM of 9.2 ± 0.78 kg/m2 and muscle mass of 21.98 ± 3.4kg. No statistically significant differences were found in the IMM between the groups (p = 0.98), although it was found in the muscle mass in kilograms (p = 0.011). Conclusion: Although the A3 population has the highest prevalence of sarcopenia, it´s interesting to find a higher prevalence of sarcopenia in young adults than in mature adults, probably by sedentary life in the new generations. We highlight the importance of evaluating muscle mass in an early age to avoid an increase of incidence of sarcopenia in older adults.


REFERENCES

  1. Planas, M. Relaciones entre el músculo y la nutrición clínica. Nutrición Hospitalaria. 2006;, 21(Supl. 3): 1.

  2. Shafiee G, Keshtkar A, Soltani A, Ahadi Z, Larijani B, Heshmat R. Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies. J Diabetes Metab Disord. 2017:16:21

  3. Rosenberg IH, Summary comments, Epidemiologic and Methodologic Problems in Determining Nutritional Status of Older Persons Am J Clin Nut 1989;50:1231–1233

  4. Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Nair KS. Sarcopenia. J Lab Clin Med 2001;137: 231–43.

  5. Cruz-Jentoft AJ, Bayens JP, Baurer JÜ, Boire Y, Cederhorm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis / Report of the European Working Group on Sarcopenia in Older People. Age and Ageing 2010; 39: 412–423.

  6. Bauer JM, Kaiser MJ, Sieber CC. Sarcopenia in nursing home residents. J Am Med Dir Assoc. 200;9:545–51.

  7. Bahat G, Saka B, Tufan F, Akin S, Sivrikaya S, Yucel N, et al. Prevalence of sarcopenia and its association with functional and nutritional status among male residents in a nursing home in Turkey. Aging Male. 2010;13:211–4

  8. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002;50:889–896.

  9. Sergi G, De Rui M, Veronese N et al. Assessing appendicular skeletal muscle mass with bioelectrical impedance analysis in free-living Caucasian older adults. Clin Nutr 2015; 34: 667–73.

  10. Kim KM, Jang HC, Lim S. Differences among skeletal muscle mass indices derived from height-, weight-, and body mass index-adjusted models in assessing sarcopenia. Korean J Intern Med. 2016;31:643-50

  11. Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gómez JM, Heitmann BL, Kent-Smith L, Melchior JC, Pirlich M, Scharfetter H, Schols AM, Pichard C; Composition of the ESPEN Working Group. Bioelectrical impedance analysis--part I: review of principles and methods. Clin Nutr. 2004;23:1226-43.

  12. Kyle UG, Bosaeus , De Lorenzo AD, Deurenberg P, Elia M, Manuel Gómez J, Lilienthal Heitmann B, Kent-Smith L, Melchior JC, Pirlich M, Scharfetter H, M W J Schols A, Pichard C; ESPEN. Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr. 2004;23:1430-53.

  13. Janssen I, Heymsfield SB, Baumgartner RN et al. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol 2000;89:465–471.

  14. Baumgartner RN, Koehler KM, Gallagher D et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998;147:755–763.

  15. Melton LJ III, Khosla S, Crowson CS et al. Epidemiology of sarcopenia. J Am Geriatr Soc 2000;48:625–630.

  16. Buendía RG, Zambrano ME, Gámez D, Reyes N, Vásquez LF, Reino AA, Morales YJ, Oyaga L, Morales A. ¿Existe sarcopenia en pacientes menores de 30 años por criterio de bioimpedanciometría? Acta Med Colomb 2015; 40: 132-137

  17. Osuna-Pozo CM, Serra-Rexach JA, Viña J, Gómez-Cabrera MC, Salvá A, Ruiz D, Masanes F, López Soto A, Formiga F, Cuesta F, Cruz-Jentoft, A. (2014). Prevalencia de sarcopenia en consultas de geriatría y residencias. Estudio ELLI. Rev Esp Geriatr Gerontol. 2014;49:72-6

  18. Salvà A, Serra-Rexach JA, Artaza I, Formiga F , Rojano i Luque X, Cuesta F, López-Soto A, Masanés F, Ruiz D, Cruz-Jentoft AJ. La prevalencia de sarcopenia en residencias de España: comparación de los resultados del estudio multicéntrico ELLI con otras poblaciones. Rev Esp Geriatr Gerontol. 2016;51:260-264

  19. Marty E, Liu Y, Samuel A, Or O, Lane J. A review of sarcopenia: Enhancing awareness of an increasingly prevalent disease. Bone. 2017 Dec;105:276-286.

  20. Tournadre A, Vial G, Capel F, Soubrier M, Boirie Y. Sarcopenia. Joint Bone Spine. 2019;86:309-314.

  21. Molina JC. Sarcopenia en la pérdida funcional: rol del ejercicio. Rev Hosp Clín Univ Chile 2008; 19: 302-8.

  22. Tasar PT, Sahin S, Karaman E, Ulusoy MG, Duman S, Berdeli A, et al. Prevalence and risk factors of sarcopenia in elderly nursing home residents. Eur Geriatr Med. 2015;6:214–9.

  23. Aras S, Yalcin A, Varli M, Cengiz Karaarslan O, Atmis V, Atli T, et al. Sarcopenia prevalence and sarcopenia related clinical conditions in elderly nursing home residents. Eur Geriatr Med. 2013;4:S20–1




2020     |     www.medigraphic.com